Application Software

AvePoint

AvePoint released FY2026 Q1 earnings on May 7 After-Market EST, actual revenue USD 117.24 M (forecast USD 116.08 M), actual EPS USD 0.07 (forecast USD 0.0425)

AvePoint to Release FY2026 Q1 Earnings on May 7 After-Market EST, Forecast Revenue USD 116.12 M, EPS USD 0.0425

B. Riley Analyst Reiterates Buy Rating on AvePoint

AvePoint Executives Discuss Data Security Governance and Introduce AgentPulse Technology

AvePoint Executives Discuss Modern Data Protection and Revenue Growth at TMT Conference

AvePoint released FY2025 annual earnings on February 26 After-Market (EST), actual revenue USD 419.5 M (forecast USD 415.61 M), actual EPS USD 0.15 (forecast USD 0.12)

AvePoint released FY2025 Q4 earnings on February 26 After-Market EST, actual revenue USD 114.69 M (forecast USD 110.94 M), actual EPS USD 0.0695 (forecast USD 0.0325)

AvePoint to Release FY2025 Q4 Earnings on February 26 After-Market EST, Forecast Revenue USD 110.94 M, EPS USD 0.0325

AvePoint Inc. to Speak at Morgan Stanley TMT Conference

AvePoint to Host Webinar Introducing New AI Governance and Data Protection Solutions

TD Cowen Analyst Maintains Buy Rating on AvePoint with $18 Price Target

AvePoint Reports 396.8% Q3 Net Profit Growth But Stock Falls 2% Due To Missed EPS

AvePoint released FY2025 9 Months Earnings on November 6 After-Market EST, with actual revenue of USD 304.81 M and EPS of USD 0.0873

AvePoint released FY2025 Q3 earnings on November 6 After-Market (EST), actual revenue USD 109.73 M (forecast USD 106.99 M), actual EPS USD 0.06 (forecast USD 0.0233)

AvePoint to release FY2025 Q3 earnings on November 6 After-Market EST, forecast revenue USD 105.72 M, EPS USD 0.0233

AvePoint Inc. to Showcase Confidence Platform Updates

Jason Ader Gives AvePoint a Buy Rating and Predicts High Growth

Gong Xunkai Sells Shares of AvePoint Inc.

AvePoint released FY2025 Semi-Annual earnings on August 7 After-Market EST, actual revenue USD 195.08 M, actual EPS USD 0.0298

AvePoint released FY2025 Q2 earnings on August 7 After-Market EST, actual revenue USD 102.02 M (forecast USD 96.29 M), actual EPS USD 0.01 (forecast USD 0.0033)

Akanda

Agape ATP

Co-Diagnostics

NewGenIvf

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Tradr 2X Long QBTS Daily ETF

Defiance Daily Target 2X Long RGTI ETF

Tradr 2X Long RGTI Daily ETF

Netcapital

PicoCELA

AVPT

Today, on May 18, 2026, AvePoint disclosed that its executive management team will be participating in investor conferences. AvePoint, a prominent figure in AI data protection, specializes in merging data security, governance, and resilience. The team will present at the conferences, reaching out to potential investors. AvePoint is listed on Nasdaq under AVPT and on SGX under AVP.

Unusual Whales

AvePoint - CW24

AvePoint to Participate in Upcoming Investor Conferences

AvePoint (NASDAQ:AVPT) reported quarterly earnings of $0.07 per share, missing estimates by $0.01. Revenue was $117.24 million, exceeding expectations of $116.12 million. The company has a net margin of 10.55% and a return on equity of 10.38%. Despite the earnings miss, shares rose 10.5% to $11.40. Analysts have mixed ratings, with a moderate buy consensus and an average price target of $16.69. Institutional investors have increased their holdings in AvePoint, indicating continued interest in the stock.

Market Beat

Gartner

B Riley Financial Pref Share RILYL 7.375 Perp 09/04/25 B

Jefferies Financial

Citigroup

US Bancorp

B Riley Financial Pref Share RILYG 7.25 12/21/27

B Riley Financial Pref Share RILYN 6.5 09/30/2026

B Riley Financial Pref Share RILYK 5.5 03/31/26

B Riley Financial Pref Share RILYP 6.875 Perp 10/07/24

B Riley Financial Pref Share RILYZ 5.25 08/31/28

B Riley Financial Pref Share RILYT 6.0 01/31/28

CITIGROUP INC 6.250 NON CUM SER II PFD WI

AvePoint (NASDAQ:AVPT) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS

AvePoint shares are trading higher after the company reported better-than-expected Q1 financial results.

benzinga_article

MSFX

AvePoint, Inc. reported Q1 2026 results with revenue of $117.24 million and net income of $15.25 million, surpassing last year's figures. The company launched major upgrades to its Confidence Platform, including a Rapid Recovery System for Microsoft 365 restoration. While the results support a positive profitability narrative, AvePoint's heavy reliance on the Microsoft ecosystem poses risks. Analysts project significant revenue growth by 2029, with a fair value estimate of $16.48, indicating a potential 60% upside from the current price. Investors are encouraged to consider both the opportunities and risks in their investment decisions.

Simplywall

T-Rex 2X Long Microsoft Daily Target ETF

NVIDIA

Microsoft

NVIDIA Corporation

Why AvePoint (AVPT) Is Up 5.8% After Q1 2026 Beat And Confidence Platform Upgrades

Earnings Watch

AvePoint | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 117.24 M

AvePoint held its 2026 annual meeting virtually, chaired by Brian Brown. Key agenda items included the election of three directors, an advisory vote on executive compensation, and the ratification of Deloitte as auditor. All proposals were approved, with directors elected and the say-on-pay proposal passed. CEO Tianyi Jiang highlighted AvePoint's strong 2025 performance, citing revenue growth and demand for data protection in the AI era, emphasizing the company's role in secure data governance.

AvePoint Annual Meeting: Directors Elected, Say-on-Pay Approved, Deloitte Ratified as Auditor

KRYS

PLTR

The U.S. market has seen a 29% increase over the past year, with earnings expected to grow by 16% annually. Key high-growth tech stocks include Marker Therapeutics, Palantir Technologies, and Krystal Biotech, showcasing significant revenue and earnings growth. AvePoint, Krystal Biotech, and Q2 Holdings are highlighted for their innovative approaches and strong financial performance, with each company adapting to market demands and focusing on AI and digital solutions. The overall trend indicates a robust environment for tech investments in the U.S.

- The U.S. market has remained flat over the last week but shows a 29% increase year-over-year, with earnings expected to grow 16% annually.  
- Key high-growth tech companies include AvePoint, Krystal Biotech, and Q2 Holdings, each demonstrating significant revenue and earnings growth, alongside strategic innovations in their fields.  
- The article emphasizes the importance of identifying companies that adapt to positive market conditions, highlighting the potential for future returns in the tech sector.

Krystal Biotech

Palantir Tech

Marker Therapeutics

Roundhill PLTR WeeklyPay ETF

iShares Semiconductor ETF

Leverage Shares 2x Cpd Acclrtd PLTRMnETF

Proshares Big Data Refiners ETF

Leverage Shares 2X Long PLTR Daily ETF

Direxion S&P Biotech Bull 3X

iShares US Digital Infrastructure and Real Estate ETF

GraniteShares 2x Long PLTR Daily ETF

SPDR S&P Biotech

Defiance Leveraged Long +Income PLTR ETF

Ark Genomic Revolution ETF

Franklin Exponential Data ETF

iShares Expanded Tech Software Sector ETF

Global X Cloud Computing ETF

ISHRS S&P Glb It

Global X Data Center & Dgtl Infrs ETF

Invesco Semiconductors ETF

Direxion Daily PLTR Bull 2X Shares

SPDR S&P Software

SPDR S&P Semicon

VanEck Semiconductor ETF

Reddit

Fabrinet

Sandisk

Tenaya Therapeutics

Zscaler

Circle

Duos Tech

Sandisk - WI

High Growth Tech Stocks To Watch In The US April 2026

B. Riley Securities analyst Erik Suppiger has reiterated a Buy rating on AvePoint (AVPT) with a price target of $22.00. Suppiger, who focuses on the Technology sector, has an average return of 18.8% and a 57.73% success rate on his stock recommendations. Additionally, AvePoint received a Buy rating from D.A. Davidson’s Rudy Kessinger on April 7, while TipRanks reiterated a Hold rating on April 1.

Tip Ranks

AvePoint (AVPT) Receives a Buy from B. Riley Securities

AvePoint(AVPT.US)